Karuna Therapeutics, Inc. (KRTX) is a publicly traded company in the Unknown sector. Across all available filings, 23 corporate insiders have executed 530 transactions totaling $683.5M, demonstrating a bearish sentiment with -$575.9M in net insider flow. The most recent transaction on Mar 18, 2024 involved a transaction of 36,117 shares valued at $11.9M.
No significant insider buying has been recorded for KRTX in the recent period.
No significant insider selling has been recorded for KRTX in the recent period.
Based on recent SEC filings, insider sentiment for KRTX is bearish with an Insider Alignment Score of 8/100 and a net flow of -$575.9M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Karuna Therapeutics, Inc. (KRTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 23 insiders are actively trading KRTX stock, having executed 530 transactions in the past 90 days. The most active insider is James Healy (Executive), who has made 29 transactions totaling $514.4M.
Get notified when executives and directors at KRTX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Mar 18, 2024 | K. Brannan Stephen | Executive | Disposition | 36,117 | $330.00 | $11.9M | Large |
| Mar 18, 2024 | K. Brannan Stephen | Executive | Disposition | 6,487 | $330.00 | $2.1M | Large |
| Mar 18, 2024 | Parker Brown Jason | Executive | Disposition | 14,009 | $330.00 | $4.6M | Large |
| Mar 18, 2024 | Parker Brown Jason | Executive | Disposition | 7,158 | $330.00 | $2.4M | Large |
| Mar 18, 2024 | J. Coughlin Christopher | Executive | Disposition | 990 | $330.00 | $326.7K | |
| Mar 18, 2024 | Healy James | Executive | Disposition | 683 | $330.00 | $225.4K | |
| Mar 18, 2024 | Healy James | Executive | Disposition | 1,372,441 | $330.00 | $452.9M | Large |
| Mar 18, 2024 | Healy James | Executive | Disposition | 8,025 | $330.00 | $2.6M | Large |
| Mar 18, 2024 | Healy James | Executive | Disposition | 990 | $330.00 | $326.7K | |
| Mar 18, 2024 | Healy James | Executive | Disposition | 32,500 | $330.00 | $10.7M | Large |
| Mar 18, 2024 | M. Jonas Jeffrey | Executive | Disposition | 990 | $330.00 | $326.7K | |
| Mar 18, 2024 | P. Kane William Jr | Executive | Disposition | 5,000 | $330.00 | $1.6M | Large |
| Mar 18, 2024 | P. Kane William Jr | Executive | Disposition | 8,828 | $330.00 | $2.9M | Large |
| Mar 18, 2024 | Meury William | Executive | Disposition | 10,342 | $330.00 | $3.4M | Large |
| Mar 18, 2024 | Meury William | Executive | Disposition | 19,037 | $330.00 | $6.3M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 211 | $629.7M | 49.2% |
Disposition(D) | 28 | $561.6M | 43.8% |
Purchase(P) | 37 | $53.8M | 4.2% |
Exercise(M) | 180 | $15.8M | 1.2% |
Other(J) | 28 | $14.9M | 1.2% |
Payment(F) | 6 | $5.0M | 0.4% |
Gift(G) | 11 | $0 | 0.0% |
Award(A) | 15 | $0 | 0.0% |
Conversion(C) | 14 | $0 | 0.0% |
Insider selling pressure at Karuna Therapeutics, Inc. has increased, with 23 insiders executing 530 transactions across all time. Total sales of $629.7M significantly outpace purchases of $53.8M, resulting in a net outflow of $575.9M. This selling activity appears largely discretionary, which may warrant closer attention from investors.